DISTRIBUTIONS OF BIOIMpEDANCE IN BREAST TISSUE WITH NEOpLASM (MODELING AND EXpERIMENT)

Yastrebov, A. V.; Trofimov, P. M.; Amosova, O. V.; Тишков, Артем; Chizh, I. A.; Шаповалов, В. В.; Kozyrev, A. B.

doi:10.21778/2218-5453-2020-2-16-22

Cited by 1 publication

(7 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…4 | products. Part 2", as well as with the results of ultrasound and the conclusion of doctors [9,10].…”

Section: Methodsmentioning

confidence: 97%

“…The handheld portable mammograph T-screen (ООО "Intellectual Program Systems" Saint Petersburg, Russia) designed for home use, which allows self-examination independently outside a medical institution, became a significant addition to the group of screening devices [7,9,10].…”

Section: Methodsmentioning

confidence: 99%

“…The software of T-screen allows, with the use of artificial intelligence methods, determining risk factors -a highly sensitive and specific parameter sensitive to neoplasms in the mammary gland, detecting fast-growing fibroadenomas, timely detection of which at stages 1 and 2-A can prevent the disease in 90 -95% of cases. It is also possible to provide quantitative assessment of the risk of neoplasms in digital form (risk factor, BIRADS level (Breast Imaging-Reporting and Data System) [9,10,13].…”

Section: Methodsmentioning

confidence: 99%

“…Observation was carried out in the preoperative period of BC treatment. The diagnosis of oncological disease was established according to the current recommendations "Breast Cancer" [9,10].…”

Section: Methodsmentioning

confidence: 99%

“…Therefore, demand for modern inexpensive and accessible tools determining the risk of developing oncology, and for screening methods to rank the population flows of women in order to identify BC risk groups at an early stage, when treatment allows achieving stable recovery in 90 -95% of patients, has sharply increased [1,4,8,10,14,15].…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

"Smart" in-House Mammograph for Breast Cancer Screening

Шаповалов¹,

Селиверстов²

2022

ArveMED

View full text Add to dashboard Cite

Breast cancer (BC) poses a serious threat to the health and life of women of all ages all over the globe. The most important task in breast cancer diagnosis is to identify the disease at an early stage. Therefore, there is a need for annual examination, primarily for women with risk factors. So, the current trend requires development and implementation of new approaches to early detection and timely treatment of BC. Among the list of new technologies for early screening is development of a portable in-house "smart" mammograph T-screen. Our clinical studies involved 198 women who used the device and confirmed its high sensitivity and specificity. The proposed method is absolutely harmless, informative, it can be used any number of times, regardless of age and pregnancy. Such data on high safety allow using T-screen widely for preventive purposes, both in early diagnosis and to detect a risk group of breast cancer in women. The methodology for using the device that we propose is simple and accessible to any user.

show abstract

“…4 | products. Part 2", as well as with the results of ultrasound and the conclusion of doctors [9,10].…”

Section: Methodsmentioning

confidence: 97%

Section: Methodsmentioning

confidence: 99%